fig3

Osimertinib in EGFR-mutated non-small cell lung cancer: a comprehensive narrative review of clinical evidence

Figure 3. Timeline of Milestone trials of osimertinib in lung cancer.

Journal of Translational Genetics and Genomics
ISSN 2578-5281 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/